AstraZeneca stops sponsoring doctors' foreign trips amid scrutiny

05/30/2011 | Reuters

AstraZeneca decided to stop paying clinicians to attend scientific meetings overseas amid regulatory scrutiny of drugmakers' financial relationship with the medical community. AstraZeneca will focus instead on "local educational opportunities," CEO David Brennan said. The drug industry reportedly paid the government $15 billion in fines during the past five years for violation of federal law.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN